Longboard pharmaceuticals provides corporate update and reports first quarter 2021 financial results

San diego, may 10, 2021 (globe newswire) -- longboard pharmaceuticals, inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today provided a corporate update and reported financial results for the first quarter ended march 31, 2021.
LBPH Ratings Summary
LBPH Quant Ranking